Testing Status of 2-Mercaptobenzimidazole 10264-H
CASRN: 583-39-1
Formula: C7-H6-N2-S
Synonyms/Common Names
- 1,3-Dihydro-2H-benzimidazole-2-thione (9CI)
Short-Term Toxicity
- 14-Day (Inhalation)
(C60980A)
Completed
- Rats: F344/N; Mice: B6C3F1
- 2 weeks (Inhalation)
(C60980B)
Completed
- Rats: F344/N; Mice: B6C3F1
- 13-Week (Inhalation)
(C60980A)
Completed
- Rats: F344/N; Mice: B6C3F1
- Dose: 0, 0.1, 10 MG/M3/10 PER GROUP.
- 13 weeks (Inhalation)
(C60980B)
Completed
- Rats: F344/N; Mice: B6C3F1
- Dose: R&M: 0, 3.13, 6.25, 12.5, 25, OR 50 MG/M3.
Special Studies
- Absorption Distribution Metabolism Excretion (Gavage; Intravenous)
(S0052)
Completed
- Citation: el Dareer SM, Kalin JR, Tillery KF, Hill DL. Disposition of 2-mercaptobenzimidazole in rats dosed orally or intravenously. J Toxicol Environ Health. 1984;14(4):595-604.Pubmed Abstract
- Male Rats: F344/N
- Dose: 0.5 mg/kg. 0.5, 49 mg/kg.
Genetic Toxicology
- In Vitro Cytogenetics (CA/SCE)
(550909)
Completed
- Sister Chromatid Exchange Positive
- Chromosome Aberrations Positive
- Micronucleus
(A06027)
Completed
- Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
- Mice: B6C3F1
- Male Negative
- Female Negative
- Mouse Lymphoma
(751815)
Completed
- Mice
- Positive
- Salmonella
(595301)
Completed
- Citation: Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen. 1987;9 Suppl 9:1-109.
- Negative